SLC35A2 (UDP-galactose translocator) variants and mutations
SLC35A2 (also known as UDP-galactose translocator) is a human protein-coding gene encoding an UDP-galactose translocator protein. It supplies UDP-galactose to the Golgi lumen for glycosylation of proteins and lipids. Germline loss-of-function variants cause a congenital disorder of glycosylation, while somatic mosaic brain variants are associated with cortical malformations and epilepsy. This analysis covers 670 SLC35A2 variants and mutations. Of these, 79% have computational variant effect predictions. Disease context includes SLC35A2-congenital disorder of glycosylation, Intellectual disability, and hereditary disease. Example SLC35A2 variants include M1I, M1K, and M1L.
Variant analysis overview
- Gene: SLC35A2
- Protein: UDP-galactose translocator
- UniProt accession: P78381
- Organism: Homo sapiens
- Variants analyzed: 670
- Variant scope: all variants
- Completed: 2026-08-02
Variant and mutation evidence
- Variant composition: 347 unspecified-consequence records; 10 frameshift variants; 226 missense variants; 60 synonymous variants; 10 stop-gained variants; 8 stop lost; 4 in-frame deletions; 1 splice-region variants; 4 substitution
- Prediction scores: 528 variants have prediction scores (79% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: SLC35A2-congenital disorder of glycosylation, Intellectual disability, hereditary disease, X-linked complex neurodevelopmental disorder, epilepsy, genetic developmental and epileptic encephalopathy, congenital disorder of glycosylation type II, congenital disorder of glycosylation, Epileptic encephalopathy, Spasticity - intellectual disability - X-linked epilepsy, developmental and epileptic encephalopathy, 1, autism.
Protein structure and variant hotspots
- Protein features: 10 transmembrane segments.
- Structural context: 363 variants have structural context.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, AlphaFold DB, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.
Notable SLC35A2 variants
Examples include M1I, M1K, M1L, M1V, A2T, A3E, A3V, V4I. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1I (p.Met1Ile), rs587776962, ClinGen CA143744, ClinVar RCV000043516, MetaLR 0.35, MetaSVM -0.43, Pathogenic
- M1K (p.Met1Lys), rs1602347908, ClinGen CA412899019, ClinVar RCV000823050, MetaLR 0.37, MetaSVM -0.26, Likely pathogenic, SLC35A2-congenital disorder of glycosylation
- M1L (p.Met1Leu), rs1042469070, ClinGen CA412899022, ClinVar RCV002246722, MetaLR 0.32, MetaSVM -0.55, Pathogenic, SLC35A2-congenital disorder of glycosylation
- M1V (p.Met1Val), rs1042469070, ClinGen CA16608936, ClinVar RCV000427117, ClinVar RCV002286410, MetaLR 0.32, MetaSVM -0.55, Uncertain significance, not provided; SLC35A2-congenital disorder of glycosylation
- A2T (p.Ala2Thr), TOPMed rs1236879702, REVEL 0.13, CADD 27.00
- A3E (p.Ala3Glu), rs946472167, ClinGen CA412898987, ClinVar RCV003582890, REVEL 0.15, CADD 31.00, Uncertain significance, SLC35A2-congenital disorder of glycosylation
- A3V (p.Ala3Val), rs946472167, ClinGen CA329102088, ClinVar RCV001046470, TOPMed rs946472167, REVEL 0.16, CADD 29.20, Benign, SLC35A2-congenital disorder of glycosylation
- V4I (p.Val4Ile), NCI-TCGA TCGA novel, TOPMed rs1557044125, gnomAD rs1557044125, REVEL 0.05, CADD 21.90, Uncertain significance, SLC35A2-congenital disorder of glycosylation
- V4L (p.Val4Leu), TOPMed rs1557044125, gnomAD rs1557044125, REVEL 0.03, CADD 22.30
- A6T (p.Ala6Thr), gnomAD rs1557044117, REVEL 0.04, CADD 22.60
- G7C (p.Gly7Cys), ExAC rs782032907, gnomAD rs782032907, REVEL 0.15, CADD 22.20
- G7V (p.Gly7Val), gnomAD rs1557044113, REVEL 0.11, CADD 21.10
- G8D (p.Gly8Asp), Ensembl rs1602347762, REVEL 0.15, CADD 17.30
- S9F (p.Ser9Phe), rs2519667774, ClinGen CA412898914, ClinVar RCV002437386, cosmic curated COSV55946, REVEL 0.12, CADD 22.00, Uncertain significance, Inborn genetic diseases
- T10A (p.Thr10Ala), gnomAD rs1054898966, REVEL 0.04, CADD 7.91
- T10P (p.Thr10Pro), gnomAD rs1054898966
- A11S (p.Ala11Ser), rs927789077, ClinGen CA329102028, ClinVar RCV001907707, ClinVar RCV005278921, REVEL 0.02, CADD 12.30, Uncertain significance, Inborn genetic diseases; SLC35A2-congenital disorder of glycosylation
- A12G (p.Ala12Gly), rs1557044100, ClinGen CA412898878, ClinVar RCV001038379, ClinVar RCV002551417, REVEL 0.12, CADD 22.50, Uncertain significance, SLC35A2-congenital disorder of glycosylation; Inborn genetic diseases
- A12P (p.Ala12Pro), gnomAD rs1557044104
- A12V (p.Ala12Val), gnomAD rs1557044100, REVEL 0.10, CADD 22.40, Uncertain significance
- P13L (p.Pro13Leu), rs2519667529, ClinGen CA412898869, ClinVar RCV003031295, REVEL 0.04, CADD 17.30, Uncertain significance, SLC35A2-congenital disorder of glycosylation
- G14R (p.Gly14Arg), NCI-TCGA Cosmic COSV5594, cosmic curated COSV55944, REVEL 0.14, CADD 21.20, Variant assessed as somatic; moderate impact.
- P15T (p.Pro15Thr), rs55719932, ClinGen CA10406217, cosmic curated COSV55946, ClinVar RCV000438491, REVEL 0.02, CADD 6.77, Benign, SLC35A2-congenital disorder of glycosylation; Inborn genetic diseases; not speci
- G16E (p.Gly16Glu), rs1173827222, ClinGen CA412898850, ClinVar RCV004459199, TOPMed rs1173827222, REVEL 0.07, CADD 17.70, Uncertain significance, Inborn genetic diseases
- G16R (p.Gly16Arg), gnomAD rs1557044094, UniProt VAR 089714, REVEL 0.03, CADD 20.60, Uncertain significance, SLC35A2-congenital disorder of glycosylation
- G16V (p.Gly16Val), TOPMed rs1173827222, gnomAD rs1173827222, REVEL 0.05, CADD 17.30, Uncertain significance, in CDG2M
- G16W (p.Gly16Trp), gnomAD rs1557044094, REVEL 0.11, CADD 22.00, Uncertain significance, in CDG2M
- A17E (p.Ala17Glu), cosmic curated COSV10582, REVEL 0.04, CADD 13.20
- A17V (p.Ala17Val), NCI-TCGA TCGA novel, REVEL 0.03, CADD 3.81, Variant assessed as somatic; moderate impact.
- V18G (p.Val18Gly), Ensembl rs2147500431
- S19F (p.Ser19Phe), rs781945687, ClinGen CA10406216, ClinVar RCV002265270, ClinVar RCV003095988, REVEL 0.09, CADD 22.20, Uncertain significance, SLC35A2-congenital disorder of glycosylation; not provided
- A20V (p.Ala20Val), rs2147500403, ClinGen CA412898802, cosmic curated COSV55946, ClinVar RCV001568089, REVEL 0.01, CADD 10.10, Uncertain significance, not provided
- A22V (p.Ala22Val), gnomAD rs1557044085, REVEL 0.01, CADD 10.10
- L23S (p.Leu23Ser), gnomAD rs1557044080
- E24D (p.Glu24Asp), rs374961453, ClinGen CA10406214, ClinVar RCV000861439, ClinVar RCV001813805, REVEL 0.05, CADD 9.34, Benign/Likely benign, SLC35A2-congenital disorder of glycosylation; not provided
- P25L (p.Pro25Leu), rs781993117, ClinGen CA10406213, NCI-TCGA Cosmic COSV9990, cosmic curated COSV99900, REVEL 0.06, CADD 21.80, Benign, SLC35A2-congenital disorder of glycosylation
- P25R (p.Pro25Arg), ExAC rs781993117, TOPMed rs781993117, gnomAD rs781993117, REVEL 0.08, CADD 22.10, Benign
- P25T (p.Pro25Thr), rs1443492116, ClinGen CA412898746, ClinVar RCV003740897, ClinVar RCV005435291, REVEL 0.04, CADD 14.40, Conflicting interpretations, SLC35A2-congenital disorder of glycosylation; not specified
- T27I (p.Thr27Ile), gnomAD rs1557044056, REVEL 0.08, CADD 15.70
- A28T (p.Ala28Thr), NCI-TCGA Cosmic COSV5594, cosmic curated COSV55944, REVEL 0.02, CADD 3.68, Variant assessed as somatic; moderate impact.
- S29N (p.Ser29Asn), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- A31T (p.Ala31Thr), NCI-TCGA TCGA novel, REVEL 0.14, CADD 33.00, Variant assessed as somatic; moderate impact.
- R34C (p.Arg34Cys), NCI-TCGA TCGA novel, REVEL 0.19, CADD 26.40, Variant assessed as somatic; moderate impact.
- R34G (p.Arg34Gly), gnomAD rs1557043672, REVEL 0.12, CADD 22.40
- R34H (p.Arg34His), rs1199079627, ClinGen CA412898068, ClinVar RCV001364069, TOPMed rs1199079627, REVEL 0.10, CADD 22.60, Uncertain significance, SLC35A2-congenital disorder of glycosylation
- R34L (p.Arg34Leu), TOPMed rs1199079627, gnomAD rs1199079627, REVEL 0.15, CADD 22.40, Uncertain significance, Inborn genetic diseases
- I38L (p.Ile38Leu), rs782268788, ClinGen CA10406190, ClinVar RCV002090265, ExAC rs782268788, REVEL 0.09, CADD 18.40, Uncertain significance, SLC35A2-congenital disorder of glycosylation
- I38T (p.Ile38Thr), cosmic curated COSV55945
- A41V (p.Ala41Val), NCI-TCGA TCGA novel, CADD 0.38, Variant assessed as somatic; moderate impact.
- L43P (p.Leu43Pro), rs1602344901, ClinGen CA412898001, ClinVar RCV000990816, Ensembl rs1602344901, AlphaMissense 1.00, MetaLR 0.51, Likely pathogenic, SLC35A2-congenital disorder of glycosylation
- Q46* (p.Gln46Ter), rs2147496735, ClinGen CA412897972, ClinVar RCV001956129, Ensembl rs2147496735, Pathogenic
- N47T (p.Asn47Thr), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- A48V (p.Ala48Val), cosmic curated COSV55945, REVEL 0.32, CADD 27.10
- S53F (p.Ser53Phe), rs782366065, gnomAD X-48905240-G-A, CADD 10.50
- R55H (p.Arg55His), rs1557043650, NCI-TCGA Cosmic COSV5594, cosmic curated COSV55946, TOPMed rs1557043650, REVEL 0.40, AlphaMissense 0.99, Uncertain significance, SLC35A2-congenital disorder of glycosylation
- R55L (p.Arg55Leu), rs1557043650, ClinGen CA412897847, ClinVar RCV001849582, TOPMed rs1557043650, AlphaMissense 0.99, MetaLR 0.35, Likely pathogenic, non-lesional focal epilepsy
- R55P (p.Arg55Pro), UniProt VAR 087467, Pathogenic, in CDG2M
- Y56C (p.Tyr56Cys), cosmic curated COSV55945
- A57T (p.Ala57Thr), rs151120284, ClinGen CA10406185, NCI-TCGA Cosmic COSV5594, cosmic curated COSV55946, REVEL 0.06, CADD 18.40, Conflicting interpretations, Inborn genetic diseases; SLC35A2-congenital disorder of glycosylation
- A57V (p.Ala57Val), cosmic curated COSV99900, REVEL 0.07, CADD 19.50
- R58C (p.Arg58Cys), rs1171450247, NCI-TCGA Cosmic COSV9990, cosmic curated COSV99900, TOPMed rs1171450247, REVEL 0.63, CADD 29.10, Variant assessed as somatic; moderate impact.
- R58H (p.Arg58His), rs1557043644, NCI-TCGA Cosmic COSV9990, cosmic curated COSV99900, gnomAD rs1557043644, AlphaMissense 0.75, MetaLR 0.39, Variant assessed as somatic; moderate impact.
- T59M (p.Thr59Met), rs782218448, ClinGen CA10406184, ClinVar RCV001894161, ExAC rs782218448, REVEL 0.44, CADD 25.50, Uncertain significance, not specified; SLC35A2-congenital disorder of glycosylation
- L60S (p.Leu60Ser), rs2519660755, ClinGen CA412897790, ClinVar RCV003582685, Uncertain significance, SLC35A2-congenital disorder of glycosylation
- P61T (p.Pro61Thr), NCI-TCGA Cosmic COSV5594, cosmic curated COSV55944, Variant assessed as somatic; moderate impact.
- P61L (p.Pro61Leu), rs782261723, gnomAD X-48905219-G-A, CADD 0.98
- D63N (p.Asp63Asn), rs2147496595, ClinGen CA412897766, ClinVar RCV002106204, Ensembl rs2147496595, AlphaMissense 0.18, MetaLR 0.15, Likely benign, SLC35A2-congenital disorder of glycosylation
- R64C (p.Arg64Cys), TOPMed rs2063519190, REVEL 0.29, CADD 25.10
- R64H (p.Arg64His), rs201465248, ClinGen CA10406182, ClinVar RCV003741085, ExAC rs201465248, REVEL 0.05, CADD 20.00, Uncertain significance, SLC35A2-congenital disorder of glycosylation
- R64K (p.Arg64Lys), rs2063481361, gnomAD X-48905243-C-T, CADD 10.30
- F65S (p.Phe65Ser), rs2147496567, ClinGen CA412897751, ClinVar RCV001998629, Ensembl rs2147496567, AlphaMissense 0.99, MetaLR 0.28, Uncertain significance, SLC35A2-congenital disorder of glycosylation
- F66S (p.Phe66Ser), rs142990922, ClinGen CA10406181, ClinVar RCV001975578, ClinVar RCV004774571, REVEL 0.37, CADD 24.20, Uncertain significance, not provided; SLC35A2-congenital disorder of glycosylation
- A67V (p.Ala67Val), rs2519660682, ClinGen CA412897735, ClinVar RCV003878510, REVEL 0.14, CADD 23.70, Uncertain significance, SLC35A2-congenital disorder of glycosylation
- T69I (p.Thr69Ile), cosmic curated COSV55946
- V71M (p.Val71Met), UniProt VAR 087470, Pathogenic, in CDG2M
- V72A (p.Val72Ala), rs1057003262, gnomAD X-48905258-A-G, CADD 8.09
- M73I (p.Met73Ile), ExAC rs782804234, gnomAD rs782804234
- M73V (p.Met73Val), TOPMed rs2063519012, gnomAD rs2063519012
- A74T (p.Ala74Thr), cosmic curated COSV10455
- A74V (p.Ala74Val), NCI-TCGA Cosmic COSV9990, cosmic curated COSV99900, Variant assessed as somatic; moderate impact.
- K78R (p.Lys78Arg), rs1569511572, ClinGen CA412897667, ClinVar RCV000766228, Ensembl rs1569511572, AlphaMissense 0.85, MetaLR 0.65, Pathogenic, SLC35A2-congenital disorder of glycosylation
- G79S (p.Gly79Ser), cosmic curated COSV10505
- G79V (p.Gly79Val), rs1057524438, ClinGen CA16608935, ClinVar RCV000423604, ClinVar RCV000536070, Uncertain significance, SLC35A2-congenital disorder of glycosylation; not provided
- L80F (p.Leu80Phe), gnomAD rs1557043626
- C82F (p.Cys82Phe), rs1557043622, ClinGen CA412897640, ClinVar RCV000560194, UniProt VAR 087471, AlphaMissense 0.99, MetaLR 0.33, Likely pathogenic, SLC35A2-congenital disorder of glycosylation
- C82R (p.Cys82Arg), rs56111636, gnomAD X-48904853-A-G, CADD 0.65
- C82S (p.Cys82Ser), rs2063479508, gnomAD X-48905084-C-G, CADD 1.46
- C82Y (p.Cys82Tyr), gnomAD X-48905201-C-T, CADD 6.10
- L86F (p.Leu86Phe), NCI-TCGA TCGA novel, REVEL 0.10, CADD 24.30, Variant assessed as somatic; moderate impact.
- A88T (p.Ala88Thr), rs1557043615, cosmic curated COSV10801, TOPMed rs1557043615, gnomAD rs1557043615, REVEL 0.04, CADD 18.20, Uncertain significance, SLC35A2-congenital disorder of glycosylation
- A88V (p.Ala88Val), rs375442287, ClinGen CA10406175, ClinVar RCV001205372, ESP rs375442287, REVEL 0.08, CADD 20.00, Benign, SLC35A2-congenital disorder of glycosylation
- A88D (p.Ala88Asp), rs1170491477, gnomAD X-48905222-G-T, CADD 6.00
- Q89R (p.Gln89Arg), rs782418208, gnomAD X-48905180-T-C, CADD 2.28
- Q89* (p.Gln89Ter), rs1557042835, gnomAD X-48905181-G-A, REVEL 0.24, CADD 16.30
- K90N (p.Lys90Asn), ExAC rs782409013, gnomAD rs782409013, cosmic curated COSV55945, REVEL 0.05, CADD 19.40
- R91C (p.Arg91Cys), rs782476110, gnomAD X-48906473-G-A, CADD 1.29
- R91H (p.Arg91His), rs782746267, []
- G92D (p.Gly92Asp), gnomAD X-48905111-C-T, CADD 7.28
- G92V (p.Gly92Val), rs144809041, gnomAD X-48905162-C-A, CADD 9.18
- V94L (p.Val94Leu), ExAC rs782610009, TOPMed rs782610009, gnomAD rs782610009, Uncertain significance
- V94M (p.Val94Met), rs782610009, ClinGen CA412896939, ClinVar RCV002253176, ClinVar RCV003933711, REVEL 0.07, CADD 17.40, Uncertain significance, SLC35A2-congenital disorder of glycosylation; See cases
- H96Q (p.His96Gln), rs1470094127, ClinGen CA412896903, ClinVar RCV002928788, Ensembl rs1470094127, AlphaMissense 0.09, MetaLR 0.03, Uncertain significance, SLC35A2-congenital disorder of glycosylation
- H96Y (p.His96Tyr), TOPMed rs1387576104
- V98A (p.Val98Ala), cosmic curated COSV54432
- V98D (p.Val98Asp), NCI-TCGA Cosmic COSV5443, cosmic curated COSV54431, Variant assessed as somatic; moderate impact.
- V98I (p.Val98Ile), rs148582301, ClinGen CA329099448, ClinVar RCV003740932, ESP rs148582301, REVEL 0.03, CADD 10.70, Benign, SLC35A2-congenital disorder of glycosylation
- L99F (p.Leu99Phe), cosmic curated COSV10505
- L99P (p.Leu99Pro), cosmic curated COSV10720
- F100L (p.Phe100Leu), cosmic curated COSV54430
- L101P (p.Leu101Pro), UniProt VAR 087472, Pathogenic, in CDG2M
- H102R (p.His102Arg), gnomAD rs1557043147, REVEL 0.23, CADD 16.40, Uncertain significance, SLC35A2-congenital disorder of glycosylation
- E103V (p.Glu103Val), rs2519651770, ClinGen CA412896817, ClinVar RCV003152647, Likely pathogenic, Congenital disorder of glycosylation
- E103* (p.Glu103Ter), rs782396941, gnomAD X-48906361-C-A, CADD 4.68
- E103K (p.Glu103Lys), rs782396941, gnomAD X-48906361-C-T, CADD 5.35
- E103D (p.Glu103Asp), rs781997019, gnomAD X-48906362-C-A, CADD 3.11
- E103G (p.Glu103Gly), rs1569511255, gnomAD X-48906362-CT-C, CADD 0.23
- A104T (p.Ala104Thr), rs782742039, gnomAD X-48906467-C-T, CADD 9.65
- L106F (p.Leu106Phe), gnomAD X-48906464-G-A, CADD 11.20
- Y109* (p.Tyr109Ter), rs2147489736, ClinGen CA412896733, ClinVar RCV001385378, Ensembl rs2147489736, AlphaMissense 0.04, Pathogenic
- Y109F (p.Tyr109Phe), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- Y109H (p.Tyr109His), TOPMed rs2063491578
- V110M (p.Val110Met), ExAC rs781902058, REVEL 0.05, CADD 13.20
- T112M (p.Thr112Met), rs1557043139, NCI-TCGA Cosmic COSV5442, cosmic curated COSV54429, gnomAD rs1557043139, REVEL 0.41, AlphaMissense 0.08, Uncertain significance
- T112R (p.Thr112Arg), rs1557043139, ClinGen CA412896715, ClinVar RCV001267207, gnomAD rs1557043139, AlphaMissense 0.08, Uncertain significance, Inborn genetic diseases
- K114* (p.Lys114Ter), rs2063491273, ClinGen CA412896705, ClinVar RCV001331522, Ensembl rs2063491273, Pathogenic
- L115A (p.Leu115Ala), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- L115F (p.Leu115Phe), rs2519651523, NCI-TCGA Cosmic COSV9950, cosmic curated COSV99504, ClinGen CA412896697, Uncertain significance, not provided
- A116P (p.Ala116Pro), rs1557043133, ClinGen CA412896686, ClinVar RCV000523416, UniProt VAR 087473, AlphaMissense 1.00, MetaLR 0.52, Likely pathogenic, not provided
- A116S (p.Ala116Ser), NCI-TCGA Cosmic COSV5442, REVEL 0.21, CADD 22.30, Variant assessed as somatic; moderate impact., in CDG2M
- A116T (p.Ala116Thr), NCI-TCGA Cosmic COSV5442, cosmic curated COSV54429, REVEL 0.49, CADD 26.10, Uncertain significance, SLC35A2-congenital disorder of glycosylation
- V117L (p.Val117Leu), gnomAD rs1557043123, REVEL 0.19, CADD 24.50
- V117A (p.Val117Ala), gnomAD X-48905126-A-G, CADD 0.36
- P118R (p.Pro118Arg), UniProt VAR 087474, Pathogenic, in CDG2M
- P118S (p.Pro118Ser), NCI-TCGA Cosmic COSV5443, NCI-TCGA Cosmic COSV9950, cosmic curated COSV99504, Variant assessed as somatic; moderate impact., in CDG2M
- P118T (p.Pro118Thr), cosmic curated COSV54430
- P118L (p.Pro118Leu), gnomAD X-48905129-G-A, CADD 2.28
- S119G (p.Ser119Gly), rs782060149, gnomAD X-48904877-T-C, CADD 11.90
- S119F (p.Ser119Phe), gnomAD X-48905096-G-A, CADD 8.18
- S119C (p.Ser119Cys), rs375311728, gnomAD X-48905159-G-C, CADD 7.66
- S119L (p.Ser119Leu), rs781951327, gnomAD X-48905186-G-A, CADD 0.56
- S119R (p.Ser119Arg), rs781811843, gnomAD X-48906470-T-G, CADD 8.03
- L120V (p.Leu120Val), gnomAD X-48906460-G-C, REVEL 0.24, CADD 22.80
- Y122H (p.Tyr122His), cosmic curated COSV54429
- T123A (p.Thr123Ala), rs2519651351, ClinGen CA412896587, ClinVar RCV003149528, Uncertain significance, not provided
- T123I (p.Thr123Ile), rs781910050, gnomAD X-48905108-G-A, CADD 6.24
- T123N (p.Thr123Asn), gnomAD X-48906450-G-T, REVEL 0.43, CADD 24.80
- L124P (p.Leu124Pro), rs782704484, gnomAD X-48905099-A-G, CADD 2.14
- N127T (p.Asn127Thr), Ensembl rs12851704
- L128I (p.Leu128Ile), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- L128V (p.Leu128Val), gnomAD X-48904862-G-C, CADD 6.94
- L128L (p.Leu128Leu), gnomAD X-48906434-G-A, CADD 11.30
- Q129* (p.Gln129Ter), rs2147489558, ClinGen CA412896507, ClinVar RCV001997611, Ensembl rs2147489558, Pathogenic
- Q129Q (p.Gln129Gln), rs367573271, gnomAD X-48906431-C-T, CADD 10.30
- Y130C (p.Tyr130Cys), UniProt VAR 087475, Pathogenic, in CDG2M
- Y130Y (p.Tyr130Tyr), gnomAD X-48906428-A-G, CADD 9.89
- V131I (p.Val131Ile), cosmic curated COSV54429
- A132V (p.Ala132Val), rs1271812540, gnomAD X-48905090-G-A, CADD 1.24
- S134L (p.Ser134Leu), gnomAD X-48905042-G-A, CADD 7.20
- P137S (p.Pro137Ser), gnomAD X-48904772-G-A, CADD 7.43
- P137L (p.Pro137Leu), gnomAD X-48905003-G-A, CADD 11.00
- P137H (p.Pro137His), rs782209341, gnomAD X-48905006-G-T, CADD 9.23
- P137R (p.Pro137Arg), gnomAD X-48905072-G-C, CADD 7.52
- P137P (p.Pro137Pro), gnomAD X-48906365-T-C, CADD 0.54
- P137T (p.Pro137Thr), gnomAD X-48906367-G-T, CADD 1.39
- P137Q (p.Pro137Gln), gnomAD X-48906408-G-T, REVEL 0.32, CADD 24.60
- A138S (p.Ala138Ser), rs1557042681, gnomAD X-48904838-C-A, CADD 7.79
- A138E (p.Ala138Glu), gnomAD X-48905066-G-T, CADD 0.08
- A138V (p.Ala138Val), rs782406133, gnomAD X-48905066-G-A, CADD 0.11
- A139V (p.Ala139Val), TOPMed rs1557043113, gnomAD rs1557043113, REVEL 0.45, CADD 28.00
- T140I (p.Thr140Ile), rs1602338152, gnomAD X-48905078-G-A, CADD 4.44
- T140P (p.Thr140Pro), gnomAD X-48906400-T-G, REVEL 0.58, CADD 28.10
- F141F (p.Phe141Phe), rs1557043107, gnomAD X-48906395-G-A, CADD 13.60
- V143V (p.Val143Val), gnomAD X-48905480-C-A, CADD 15.10
- V143A (p.Val143Ala), gnomAD X-48905481-A-G, REVEL 0.38, CADD 28.10
- T144M (p.Thr144Met), rs781917175, gnomAD X-48905036-G-A, CADD 0.25
- T144I (p.Thr144Ile), gnomAD X-48905478-G-A, REVEL 0.69, CADD 26.50
- Y145C (p.Tyr145Cys), gnomAD X-48905060-T-C, CADD 0.17
- Y145Y (p.Tyr145Tyr), gnomAD X-48905474-G-A, CADD 9.48
- Q146K (p.Gln146Lys), gnomAD X-48905473-G-T, REVEL 0.61, CADD 26.40
- L147L (p.Leu147Leu), gnomAD X-48905468-C-T, CADD 13.90
Public SLC35A2 analysis runs
- SLC35A2 analysis run — SLC35A2 (670 variants) — completed 2026-08-02